Caspase enzyme activity is not essential for apoptosis during thymocyte development |
| |
Authors: | Doerfler P Forbush K A Perlmutter R M |
| |
Affiliation: | Department of Immunology and Rheumatology, Merck Research Laboratories, Rahway, NJ 07065, USA. Petra_Doerfler@merck.com |
| |
Abstract: | Caspases, a family of cysteine proteases, are critical mediators of apoptosis. To address the importance of caspases in thymocyte development, we have generated transgenic mice that express the baculovirus protein p35, a viral caspase inhibitor, specifically in the thymus. p35 expression inhibited Fas (CD95)-, CD3-, or peptide-induced caspase activity in vitro and conferred resistance to Fas-induced apoptosis. However, p35 did not block specific peptide-induced negative selection in OT1 and HY TCR transgenic mouse models. Even the potent pharmacological caspase inhibitor zVAD-FMK (benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl-ketone) could not prevent peptide-induced deletion of OT1 thymocytes, although it improved basal thymocyte survival in vitro. Moreover, the developmental block observed in rag1-/- thymocytes, which lack pre-TCR signaling, was also not rescued by p35 expression. These results indicate that caspase-independent signal transduction pathways can mediate thymocyte death during normal T cell development. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|